Sugi Predict

Sugi Predict / Compounds / SCHEMBL19829506

SCHEMBL19829506

SCHEMBL19829506

CC(C)(C)OC(=O)N[C@]1(c2ccc(-c3ncc(N)cc3-c3ccccc3)cc2)C[C@@H](F)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 6/20 0.39
▸ AKT2 P31751 4/20 0.39
▸ CKS1B P61024 5/20 0.39
▸ SKP1 P63208 5/20 0.39
▸ SKP2 Q13309 5/20 0.39
▸ SCN9A Q15858 1/20 0.37
▸ CNR1 P21554 2/20 0.34
▸ CNR2 P34972 2/20 0.34
▸ ALOX5AP P20292 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ ACACB O00763 1/20 0.33
▸ ACACA Q13085 1/20 0.33
▸ MALT1 Q9UDY8 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ PDE5A O76074 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17885126 0.92 AKT1 (0.40) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17885232 0.90 AKT1 (0.46) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17885235 0.88 AKT1 (0.40) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17885229 0.88 AKT1 (0.49) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17872579 0.87 AKT1 (0.44) AKT1AKT2SCN9AMALT1DHODH
SCHEMBL17872551 0.87 AKT1 (0.44) AKT1AKT2SCN9AMALT1DHODH
SCHEMBL17885272 0.86 AKT1 (0.40) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17885240 0.80 AKT1 (0.44) AKT1AKT2
SCHEMBL17885279 0.80 AKT1 (0.44) AKT1AKT2CKS1BSKP1SKP2
SCHEMBL17872430 0.78 CKS1B (0.35) AKT1AKT2CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070708-A1 Pharmaceutically Active Compounds BERGENBIO ASA (NO) 2021-03-11 — — US disclosed
US-10766861-B2 Pharmaceutically active compounds BERGENBIO ASA (NO) 2020-09-08 — — US disclosed
US-10336702-B2 Pharmaceutically active compounds BERGENBIO ASA (NO) 2019-07-02 — — US disclosed
US-20180029985-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS BERGENBIO AS (NO) 2018-02-01 — — US disclosed
US-20180029985-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS BERGENBIO AS (NO) 2018-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336702-B2 Pharmaceutically active compounds UGT2B7, CYP3A5, UGT1A1 AKT1 2288/4885AKT2 1340/4885CKS1B 1509/4885
US-20210070708-A1 Pharmaceutically Active Compounds UGT2B7, CYP3A5, UGT1A1 AKT1 2193/4885AKT2 1292/4885CKS1B 1415/4885
US-10766861-B2 Pharmaceutically active compounds UGT2B7, CYP3A5, UGT1A1 AKT1 2193/4885AKT2 1292/4885CKS1B 1415/4885
US-20180029985-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS UGT2B7, CYP3A5, UGT1A1 AKT1 2288/4885AKT2 1340/4885CKS1B 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.